The Cumulative Effect of Acute Rejection on Development of Cardiac Allograft Vasculopathy
- 30 April 2006
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 25 (4) , 420-425
- https://doi.org/10.1016/j.healun.2005.11.449
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Endothelial Activation in the Transplanted Human Heart From Organ Retrieval to 3 Months After Transplantation: An Observational StudyThe Journal of Heart and Lung Transplantation, 2005
- Prevention of Cardiac Allograft Vasculopathy With Certican® (Everolimus): The Stanford University Experience Within the Certican Phase III Clinical TrialThe Journal of Heart and Lung Transplantation, 2005
- Does acute cellular rejection correlate with cardiac allograft vasculopathy?The Journal of Heart and Lung Transplantation, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Diagnostic accuracy of coronary angiography and risk factors for post–heart-transplant cardiac allograft vasculopathyTransplantation, 2003
- Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound studyThe Journal of Heart and Lung Transplantation, 2001
- CARDIAC ALLOGRAFT REJECTION LATE AFTER TRANSPLANTATION IS A RISK FACTOR FOR GRAFT CORONARY ARTERY DISEASETransplantation, 1998
- HUMAN LEUKOCYTE ANTIGEN COMPATIBILITY IN HEART TRANSPLANTATIONTransplantation, 1997
- Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipientsTransplantation Proceedings, 1997
- Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matchingThe Lancet, 1995